Feedback / Questions
AVA6000 - Avacta
https://www.globenewswire.com/news-release/2025/03/07/3039002/0/en/Avacta-Announces-Promising-Early-Efficacy-and-Safety-Data-for-AVA6000-in-the-Phase-1a-Dose-Escalation-and-Ongoing-Enrollment-in-the-Phase-1b-Expansion-Cohorts.html
Mar 7, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next